ARCA Biopharma Inc
NASDAQ:ABIO

Watchlist Manager
ARCA Biopharma Inc Logo
ARCA Biopharma Inc
NASDAQ:ABIO
Watchlist
Price: 2.4 USD -4%
Market Cap: 10.9B USD

Relative Value

There is not enough data to reliably calculate the relative value of ABIO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABIO Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.5
vs History
vs Industry
Median 3Y
-6 349.1
Median 5Y
-6 407.1
Industry
23.6
Forward
-89.7
vs History
vs Industry
Median 3Y
-5 775.4
Median 5Y
-6 521
Industry
20.2
vs History
vs Industry
Median 3Y
-5 774.4
Median 5Y
-6 501.4
Industry
22.9
vs History
80
vs Industry
0
Median 3Y
1 398.7
Median 5Y
1 448
Industry
2.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
14
Median 3Y
-5 954.9
Median 5Y
-6 185.2
Industry
4.9
vs History
vs Industry
12
Median 3Y
-5 943.7
Median 5Y
-6 179.1
Industry
4.9
Forward
-147.2
vs History
vs Industry
15
Median 3Y
-5 771.5
Median 5Y
-6 516.4
Industry
5.4
vs History
vs Industry
11
Median 3Y
-5 770.5
Median 5Y
-6 501.5
Industry
4
vs History
vs Industry
7
Median 3Y
85 936.7
Median 5Y
86 305.4
Industry
5.1

Multiples Across Competitors

ABIO Competitors Multiples
ARCA Biopharma Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ARCA Biopharma Inc
NASDAQ:ABIO
10.9B USD 0 -1 516.6 -1 193.9 -1 192.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 182 884.2 -162 466.2 -197 285.8 -195 034.5
US
Abbvie Inc
NYSE:ABBV
338.4B USD 5.9 81.5 15.5 22.9
US
Amgen Inc
NASDAQ:AMGN
160.2B USD 4.7 27 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
135.7B USD 4.7 22.8 9.9 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.9B USD 10.8 -121 25.8 27
US
Epizyme Inc
F:EPE
94.1B EUR 2 060.9 -525.9 -572.7 -557.4
AU
CSL Ltd
ASX:CSL
120.3B AUD 5.2 28.6 17.6 22
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.6B USD 4.2 13.2 11.8 13.3
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.9B USD 17.8 -155.4 -697.1 -349.3
P/S Multiple
Revenue Growth P/S to Growth
US
ARCA Biopharma Inc
NASDAQ:ABIO
Average P/S: 3 418 501.8
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 182 884.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.8
10%
1.1
US
E
Epizyme Inc
F:EPE
2 060.9
N/A N/A
AU
CSL Ltd
ASX:CSL
5.2
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1.1
US
S
Seagen Inc
F:SGT
19.9
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.8
30%
0.6
P/E Multiple
Earnings Growth PEG
US
ARCA Biopharma Inc
NASDAQ:ABIO
Average P/E: 34.6
Negative Multiple: -1 516.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 466.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.8
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -121 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.9 N/A N/A
AU
CSL Ltd
ASX:CSL
28.6
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
ARCA Biopharma Inc
NASDAQ:ABIO
Average EV/EBITDA: 15.9
Negative Multiple: -1 193.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 285.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.6
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -697.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
ARCA Biopharma Inc
NASDAQ:ABIO
Average EV/EBIT: 20.5
Negative Multiple: -1 192.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 034.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.4 N/A N/A
AU
CSL Ltd
ASX:CSL
22
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.3
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -349.3 N/A N/A